Immune to Cancer: The CRI Blog
-
Sarcomas: Unique Cancers that Merit Further Attention and Research
Sarcomas are unique compared to other types of cancer variations. In contrast to carcinomas, which arise from… -
Why Do We Get Cancer? How Our Lifestyles Impact Our Risk
There are many factors that dictate whether someone will develop cancer, and they fall roughly into two… -
<strong><u>AACR 2023 Recap: CRI Scientists Tackle the Frontiers of Cancer Immunotherapy</u></strong>
More than any conference yet, the 2023 annual meeting of the American Association for Cancer Research (AACR… -
AACR 2023 Preview: Advancing the Frontiers of Cancer Science and Medicine
From April 14-19, the 2023 AACR annual meeting highlights a broad scope of immunotherapy breakthroughs, including cell… -
<strong>A Conversation with CRI ImmunoAdvocate Karen Peterson</strong>
Karen Peterson shares her journey from an immunotherapy clinical trial to patient advocate working to improve clinical… -
5 Things Patients, Caregivers, and Families Need to Know About Cancer
Our CEO speaks with Medium/Authority Magazine about cancer, immunotherapy, and how she became CEO of the world’s… -
Engineering Better CAR T Cells with CRI Lloyd J. Old STAR Yvonne Chen
CRI STAR Yvonne Chen is exploring several strategies to improve the safety and effectiveness of CAR T… -
Clinical Trials Drive Immunotherapy Progress. Are They for You?
Immunotherapy clinical trials are critical endeavors that lead to breakthrough cancer treatments.
-
Dr. Dmitriy Zamarin Answers Questions About Ovarian Cancer and Immunotherapy after the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Dmitriy Zamarin, of Memorial Sloan Kettering Cancer Center, answers questions about immunotherapy clinical trials from the…